Aerovate Therapeutics Inc
General ticker "AVTE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $75.2M
Aerovate Therapeutics Inc does not follow the US Stock Market performance with the rate: -39.3%.
Estimated limits based on current volatility of 2.1%: low 2.50$, high 2.61$
Factors to consider:
- Current price 77.2% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [11.23$, 24.75$]
- 2024-12-30 to 2025-12-30 estimated range: [8.71$, 20.22$]
Financial Metrics affecting the AVTE estimates:
- Negative: Non-GAAP EPS, $ of -2.88 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -10.86 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term AVTE quotes
Long-term AVTE plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $23.02MM | $53.24MM | $81.41MM |
Operating Income | $-23.02MM | $-53.24MM | $-81.41MM |
Non-Operating Income | $0.06MM | $1.75MM | $5.94MM |
Interest Expense | $0.07MM | $0.00MM | $0.00MM |
R&D Expense | $14.99MM | $38.62MM | $64.22MM |
Income(Loss) | $-22.96MM | $-51.49MM | $-75.47MM |
Taxes | $0.00MM | $0.03MM | $0.06MM |
Profit(Loss) | $-22.96MM | $-51.51MM | $-75.52MM |
Stockholders Equity | $172.42MM | $126.74MM | $109.46MM |
Assets | $175.36MM | $135.30MM | $127.42MM |
Operating Cash Flow | $-27.40MM | $-39.12MM | $-56.78MM |
Capital expenditure | $0.18MM | $0.20MM | $0.14MM |
Investing Cash Flow | $-113.43MM | $6.93MM | $11.88MM |
Financing Cash Flow | $190.46MM | $0.40MM | $46.00MM |
Earnings Per Share* | $-0.94 | $-2.10 | $-2.87 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.